Source: Einstein (São Paulo). Unidade: ICB
Subjects: FISIOLOGIA, ANTIRRETROVIRAIS, TECIDO ADIPOSO, LEPTINA, FARMACOTERAPIA, ÁCIDOS GRAXOS
ABNT
ZANARDO, Luiza Wolf et al. Combined tenofovir, lamivudine, and dolutegravir treatment increases leptin and FABP4 expression in human subcutaneous adipose tissue. Einstein (São Paulo), v. 24, 2026Tradução . . Disponível em: https://doi.org/10.31744/einstein_journal/2026AO1770. Acesso em: 05 abr. 2026.APA
Zanardo, L. W., Izabel, L. dos S., Hamada, L. M., Carvalho, M. B. de, Silva, P. A. G. O. e, Joaquim, H. D. G., et al. (2026). Combined tenofovir, lamivudine, and dolutegravir treatment increases leptin and FABP4 expression in human subcutaneous adipose tissue. Einstein (São Paulo), 24. doi:10.31744/einstein_journal/2026AO1770NLM
Zanardo LW, Izabel L dos S, Hamada LM, Carvalho MB de, Silva PAGO e, Joaquim HDG, Santoro S, Festuccia WTL, Magdalon J. Combined tenofovir, lamivudine, and dolutegravir treatment increases leptin and FABP4 expression in human subcutaneous adipose tissue [Internet]. Einstein (São Paulo). 2026 ; 24[citado 2026 abr. 05 ] Available from: https://doi.org/10.31744/einstein_journal/2026AO1770Vancouver
Zanardo LW, Izabel L dos S, Hamada LM, Carvalho MB de, Silva PAGO e, Joaquim HDG, Santoro S, Festuccia WTL, Magdalon J. Combined tenofovir, lamivudine, and dolutegravir treatment increases leptin and FABP4 expression in human subcutaneous adipose tissue [Internet]. Einstein (São Paulo). 2026 ; 24[citado 2026 abr. 05 ] Available from: https://doi.org/10.31744/einstein_journal/2026AO1770
